The measured absorbance reflects the amount of crystal violet retained by the fixed, stained cell material after washing and, when used, solubilization. Because retained dye is associated with cells remaining attached to the culture surface, the signal supports relative estimates of adherent cell abundance across samples rather than an independent measure of every cell originally present.
Fixation keeps adherent cells in place during processing, while crystal violet staining marks the retained cellular material. Washing removes unbound dye that could increase background and weaken comparisons. Solubilization can then prepare the retained stain for absorbance measurement. Together, these steps connect the optical signal to cell-associated material under the tested conditions.
Consistent cell attachment and staining conditions are central to reliable results. Differences in how many cells remain attached, how evenly samples are stained, or how effectively unbound dye is removed can alter absorbance independently of the treatment effect. Standardizing these conditions helps make comparisons between cancer-cell cultures, compounds, and doses more meaningful.
Cells are first cultured and exposed to the experimental treatment. After treatment, the cells are fixed in place, stained with crystal violet, and washed to remove dye that did not bind to the sample. The retained stain is often solubilized before absorbance is measured, allowing conditions to be compared using the resulting colorimetric signal.
Cancer researchers can use the method for rapid comparisons of cell growth, cytotoxicity, and treatment effects across experimental conditions. Its low cost and compatibility with multiwell formats make it practical for preliminary compound screening, where many conditions can be evaluated in parallel, and for dose-response studies that compare how treatment levels affect adherent cell material.
By applying different treatment conditions to cultured cancer cells and comparing absorbance after staining, researchers can identify relative differences in retained cellular material across doses. The assay therefore provides a practical first-pass view of treatment effects and supports dose-response comparisons, while consistent attachment and staining remain necessary for interpreting differences as meaningful experimental outcomes.